Atea Pharmaceuticals, Inc. (AVIR)
5.33
+0.07
(+1.33%)
USD |
NASDAQ |
Sep 18, 16:00
5.32
-0.01
(-0.19%)
After-Hours: 20:00
Atea Pharmaceuticals Price to Book Value : 2.094 for Sept. 18, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 2.094 |
| September 17, 2026 | 2.066 |
| September 16, 2026 | 2.023 |
| September 15, 2026 | 2.055 |
| September 14, 2026 | 2.09 |
| September 11, 2026 | 2.086 |
| September 10, 2026 | 2.035 |
| September 09, 2026 | 2.070 |
| September 08, 2026 | 2.231 |
| September 04, 2026 | 2.290 |
| September 03, 2026 | 2.286 |
| September 02, 2026 | 2.239 |
| September 01, 2026 | 2.157 |
| August 31, 2026 | 2.102 |
| August 28, 2026 | 2.106 |
| August 27, 2026 | 2.141 |
| August 26, 2026 | 2.165 |
| August 25, 2026 | 2.133 |
| August 24, 2026 | 2.165 |
| August 21, 2026 | 2.133 |
| August 20, 2026 | 2.106 |
| August 19, 2026 | 2.196 |
| August 18, 2026 | 2.074 |
| August 17, 2026 | 2.051 |
| August 14, 2026 | 2.011 |
| Date | Value |
|---|---|
| August 13, 2026 | 1.992 |
| August 12, 2026 | 1.988 |
| August 11, 2026 | 1.984 |
| August 10, 2026 | 1.972 |
| August 07, 2026 | 2.062 |
| August 06, 2026 | 1.960 |
| August 05, 2026 | 1.866 |
| August 04, 2026 | 1.846 |
| August 03, 2026 | 1.811 |
| July 31, 2026 | 1.846 |
| July 30, 2026 | 1.862 |
| July 29, 2026 | 1.815 |
| July 28, 2026 | 1.772 |
| July 27, 2026 | 1.894 |
| July 24, 2026 | 1.858 |
| July 23, 2026 | 1.866 |
| July 22, 2026 | 1.890 |
| July 21, 2026 | 1.913 |
| July 20, 2026 | 1.876 |
| July 17, 2026 | 1.913 |
| July 16, 2026 | 1.852 |
| July 15, 2026 | 1.909 |
| July 14, 2026 | 1.846 |
| July 13, 2026 | 1.862 |
| July 10, 2026 | 1.960 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Filana Therapeutics, Inc. | 0.5514 |
| CorMedix, Inc. | 1.301 |
| Eloxx Pharmaceuticals, Inc. | 1.517 |
| Breakthrough Chemistry, Inc. | 1.523 |
| BioStem Technologies, Inc. | 3.059 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0857 |
| Price | 5.33 |
| Earnings Yield | -39.24% |
| Market Cap | 427.49M |
| PEGY Ratio | -0.0857 |